MACROGENICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
MACROGENICS, INC. (MGNX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $6.99 million as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2017-11-08
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $6.99M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $6.39M.
- 2015-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.05M.
- 2014-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $916.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2017-09-30 | $6.99M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $6.39M 10-Q · filed 2017-08-02 |
| 2015-09-30 | $1.05M 10-Q · filed 2015-11-04 |
| 2014-09-30 | $916.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $3.65M 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |